Ads
related to: glaxosmithkline- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Sign Up
Sign Up for Updates, News
and Much More.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Careers
Search results
H5N1 bird flu human case confirmed in Michigan dairy worker: What to know about risks
Detroit Free Press· 57 minutes agoA second human case of bird flu was confirmed in a dairy worker in Michigan, U.S. government...
WHISTLEBLOWER ALLEGES GLAXOSMITHKLINE LIED ABOUT ZANTAC SAFETY CLAIMS
WFRV 5 Green Bay· 3 days agoValisure, Represented by Wisner Baum, alleges in qui tam suit that GlaxoSmithKline (GSK) lied to the FDA and Federal Government about the ability of its "blockbuster" drug ...
Prostate Cancer Screening: What Does Your Patient Fear Most?
Medscape· 1 day agoDr Neil Skolnik distills available recommendations (including recent AUA guidance) to help...
GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
Reuters via Yahoo Finance· 6 days agoDrugmaker GlaxoSmithKline Pharma India reported a 49% rise in fourth-quarter adjusted profit on Friday, as strong demand for its generic medicines offset the impact of the ...
GSK faces whistleblower lawsuit over Zantac cancer risk
WSAU Wausau· 3 days agoBy Jonathan Stempel (Reuters) - GSK has been sued by an independent Connecticut laboratory that...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 2 hours agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Marti Technologies names new CFO By Investing.com
Investing.com· 6 days agoMarti Technologies, Inc. (NYSE American: MRT), a prominent mobility service provider in Türkiye, today announced the appointment of Oguz Erkan as its new...
GSK Faces Whistleblower Suit From Lab That Found Zantac Risk
Insurance Journal· 2 days agoGSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from...
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 3 days agoAfter several years of speculation Tempus would go public, the AI-enabled precision-medicine startup from Eric Lefkofsky filed for an initial public offering today. The company, founded in 2015 ...
Dime for a Dame
Bloomberg· 6 days agoGet briefed ahead of your morning calls with the latest UK business headlines, key data and market reaction